path 2 - Biology bibliographies - in Harvard style

In-text: (Aareleid, Zimmermann, Baburin and Innos, 2017)

Your Bibliography: Aareleid, T., Zimmermann, M., Baburin, A. and Innos, K., 2017. Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study. BMC Cancer, 17(1).

In-text: (Angeli et al., 2013)

Your Bibliography: Angeli, J., Cruz Pereira, C., de Oliveira Faria, T., Stefanon, I., Padilha, A. and Vassallo, D., 2013. Cadmium exposure induces vascular injury due to endothelial oxidative stress: the role of local angiotensin II and COX-2. Free Radical Biology and Medicine, 65, pp.838-848.

In-text: (Angelidis et al., 2019)

Your Bibliography: Angelidis, I., Simon, L., Fernandez, I., Strunz, M., Mayr, C., Greiffo, F., Tsitsiridis, G., Ansari, M., Graf, E., Strom, T., Nagendran, M., Desai, T., Eickelberg, O., Mann, M., Theis, F. and Schiller, H., 2019. An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics. Nature Communications, 10(1).

In-text: (Baine et al., 2020)

Your Bibliography: Baine, M., Hsieh, M., Lai, W., Egger, J., Jungbluth, A., Daneshbod, Y., Beras, A., Spencer, R., Lopardo, J., Bodd, F., Montecalvo, J., Sauter, J., Chang, J., Buonocore, D., Travis, W., Sen, T., Poirier, J., Rudin, C. and Rekhtman, N., 2020. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization. Journal of Thoracic Oncology, 15(12), pp.1823-1835.

In-text: (Cao and Chen, 2018)

Your Bibliography: Cao, M. and Chen, W., 2018. Epidemiology of lung cancer in China. Thoracic Cancer, 10(1), pp.3-7.

In-text: (Chi et al., 2017)

Your Bibliography: Chi, Y., Jin, Q., Liu, X., Xu, L., He, X., Shen, Y., Zhou, Q., Zhang, J. and Jin, M., 2017. miR‐203 inhibits cell proliferation, invasion, and migration of non‐small‐cell lung cancer by downregulating RGS 17. Cancer Science, 108(12), pp.2366-2372.

In-text: (Elkbuli et al., 2020)

Your Bibliography: Elkbuli, A., Byrne, M., Zhao, W., Sutherland, M., McKenney, M., Godinez, Y., Dave, D., Bouzoubaa, L. and Koru-Sengul, T., 2020. Gender disparities in lung cancer survival from an enriched Florida population-based cancer registry. Annals of Medicine and Surgery, 60, pp.680-685.

In-text: (Harrison, Vyse and Huang, 2020)

Your Bibliography: Harrison, P., Vyse, S. and Huang, P., 2020. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer. Seminars in Cancer Biology, 61, pp.167-179.

In-text: (Koeller, Chen and Oxnard, 2018)

Your Bibliography: Koeller, D., Chen, R. and Oxnard, G., 2018. Hereditary Lung Cancer Risk: Recent Discoveries and Implications for Genetic Counseling and Testing. Current Genetic Medicine Reports, 6(2), pp.83-88.

In-text: (Koeller, Chen and Oxnard, 2018)

Your Bibliography: Koeller, D., Chen, R. and Oxnard, G., 2018. Hereditary Lung Cancer Risk: Recent Discoveries and Implications for Genetic Counseling and Testing. Current Genetic Medicine Reports, 6(2), pp.83-88.

In-text: (Kolewe, Feng and Fromen, 2021)

Your Bibliography: Kolewe, E., Feng, Y. and Fromen, C., 2021. Realizing Lobe-Specific Aerosol Targeting in a 3D-Printed In Vitro Lung Model. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 34(1), pp.42-56.

In-text: (Leone and Powell, 2020)

Your Bibliography: Leone, R. and Powell, J., 2020. Metabolism of immune cells in cancer. Nature Reviews Cancer, 20(9), pp.516-531.

In-text: (Popat et al., 2020)

Your Bibliography: Popat, S., Grohé, C., Corral, J., Reck, M., Novello, S., Gottfried, M., Radonjic, D. and Kaiser, R., 2020. Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?. Lung Cancer, 144, pp.76-84.

In-text: (Saab et al., 2021)

Your Bibliography: Saab, M., Noonan, B., Kilty, C., FitzGerald, S., Collins, A., Lyng, Á., Kennedy, U., O'Brien, M. and Hegarty, J., 2021. Awareness and help-seeking for early signs and symptoms of lung cancer: A qualitative study with high-risk individuals. European Journal of Oncology Nursing, 50, p.101880.

In-text: (Sun et al., 2021)

Your Bibliography: Sun, K., Zheng, R., Zeng, H., Zhang, S., Zou, X., Gu, X., Xia, C., Yang, Z., Li, H., Chen, W. and He, J., 2021. [The incidence and mortality of lung cancer in China, 2014]. [online] PubMed. Available at: <https://pubmed.ncbi.nlm.nih.gov/30481929/> [Accessed 2 December 2021].

In-text: (Zhang et al., 2021)

Your Bibliography: Zhang, S., Zheng, R., Yang, Z., Zeng, H., Sun, K., Gu, X., Li, H., Chen, W. and He, J., 2021. [Trend analysis on incidence and age at diagnosis for lung cancer in cancer registration areas of China, 2000-2014]. [online] PubMed. Available at: <https://pubmed.ncbi.nlm.nih.gov/29886678/> [Accessed 1 December 2021].